SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

Search

Imerys SA.

Abrir

SetorSaúde

22.12 0.82

Visão Geral

Variação de preço das ações

24h

Atual

Mín

21.88

Máximo

22.18

Indicadores-chave

By Trading Economics

Rendimento

-550M

-479M

Vendas

-130M

1.6B

P/E

Médio do Setor

13.076

60.328

EPS

-5.667

Rendimento de Dividendos

3.28

Margem de lucro

-29.457

Funcionários

14,878

EBITDA

-310M

-43M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+17.14% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.28%

2.24%

Próximos Ganhos

29 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-295M

1.9B

Abertura anterior

21.3

Fecho anterior

22.12

Sentimento de Notícias

By Acuity

58%

42%

305 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Imerys SA. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank -2-

24 de abr. de 2026, 19:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Group Rejects EQT's Revised Offer

26 de abr. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 de abr. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Falls Amid Dollar's Strength -- Market Talk

26 de abr. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 de abr. de 2026, 23:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Scoring the Cook Era -- Barrons.com

24 de abr. de 2026, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

24 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:09 UTC

Ganhos

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 de abr. de 2026, 19:48 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 de abr. de 2026, 19:22 UTC

Ganhos

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 de abr. de 2026, 19:06 UTC

Ganhos

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 de abr. de 2026, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 de abr. de 2026, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 de abr. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Rejects Revised EQT Offer

24 de abr. de 2026, 18:12 UTC

Conversa de Mercado

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 de abr. de 2026, 18:06 UTC

Conversa de Mercado

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 de abr. de 2026, 17:42 UTC

Ganhos

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 de abr. de 2026, 17:28 UTC

Ganhos

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Comparação entre Pares

Variação de preço

Imerys SA. Previsão

Preço-alvo

By TipRanks

17.14% parte superior

Previsão para 12 meses

Média 25.7 EUR  17.14%

Máximo 28.4 EUR

Mínimo 23 EUR

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Imerys SA. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

29.06 / 30.24Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

305 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Imerys SA.

Imerys S.A. provides mineral-based specialty solutions for various industries worldwide. The company provides additives for paints, coatings, adhesives, caulks, sealants, and rubber; minerals for technical ceramics and traditional ceramics; functional additives for plastics and thermoset; high-performance binders for dry mix mortars and floor screeds; fillers and coatings for paper, board, and packaging applications; filtration agents for liquids and blood plasma; pharmaceutical diluents, coloring agents, processing aids, glidants, and lubricants for tablet production; engineered minerals for cosmetic industry; food additives to preserve flavor; coating agents to improve fertilizer fow; mineral-based cat litters; alumina for high-performance abrasives and graphite in brake pads; and carbon black for conductivity in onboard data systems. The company also offers minerals used to produce high purity silicon metal for electronics and solar panels; graphite and carbon-based solutions for industrial applications; mineral solutions for batteries and energy storage; refractory minerals and solutions for high-temperature processes; and alumina and zirconia for abrasives. It serves construction and infrastructure, consumer and health care, automotive and transportation, energy and electronics, and industry and equipment industries. The company was incorporated in 1880 and is headquartered in Paris, France. The company is a subsidiary of Belgian Securities BV.
help-icon Live chat